Temozolomide (Mayne Pharma Inc.)
Welcome to the PulseAid listing for the Temozolomide drug offered from Mayne Pharma Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayne Pharma Inc. |
| NON-PROPRIETARY NAME: | Temozolomide |
| SUBSTANCE NAME: | TEMOZOLOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-10 |
| END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Temozolomide from Mayne Pharma Inc. |
| LABELER NAME: | Mayne Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2016-10-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51862-083_1dd2cff6-3b64-4245-9d14-1002b74f2732 |
| PRODUCT NDC: | 51862-083 |
| APPLICATION NUMBER: | ANDA206413 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers:
